services and capabilities

We support global health and research efforts using our diverse geographic and therapeutic area expertise. Download these resources to learn more about our services and capabilities. 

Full-Service Global Support for COVID-19 Studies

Our broad expertise, end-to-end services and ability to begin immediate collaboration with government, commercial and academic partners in more than 60 countries make us uniquely positioned to support the COVID-19 response.

Vaccine Development

To achieve our vision of a world where advances in vaccines help all people live longer, healthier lives, we’ve honed our processes to respond to the urgency and complexity of vaccine trials, developed our global network of investigators and sites, and partnered with organizations across public, private, academic and government sectors.

About the PREVAIL Network

The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network was established through a partnership between local Liberian and international partners, including the U.S. National Institutes of Health, World Health Organization and FHI Clinical, to provide sustainable research infrastructure to address diseases of public health importance.

Sustaining Research Capacity Worldwide

Through our collaborative relationships with government, commercial and academic partners in 60+ countries, we can develop and sustain sites that are ready to accept new projects and can guarantee excellent quality and value. This increased research capacity will help address global public health issues.

About FHI Clinical

We manage complex clinical research in resource-limited settings around the world. Whether it requires working from a state-of-the‑art facility or in a low-tech, rural setting, we provide services tailored to meet your study needs, from protocol design and site assessments to trial planning, implementation and management.